← back to search

Tyra Grove Krause

Statens Serum Institut · DK
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, and Vaccine Coverage and Hesitancy.
h-index
44
citations
9,629
works
195
NIH funding
primary concept
Medicine
email

Recent publications

Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of 2 Nationwide Randomized Trials
Clinical Infectious Diseases 2026cited by 0position: middledoi
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
NEJM Evidence 2025cited by 2position: middledoi
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial
European Heart Journal Open 2025cited by 1position: middledoi
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases
JAMA 2024cited by 34position: middledoi
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial
Nature Medicine 2024cited by 17position: middledoi
Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
American Heart Journal 2024cited by 10position: middledoi
Electronic Nudge Letters to Increase Influenza Vaccination Uptake in Younger and Middle-Aged Individuals With Diabetes
JACC Advances 2024cited by 4position: middledoi
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
The Lancet Infectious Diseases 2022cited by 105position: middledoi
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
The Lancet Regional Health - Europe 2022cited by 60position: middledoi
All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States
Influenza and Other Respiratory Viruses 2022cited by 18position: lastdoi
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
The Lancet 2017cited by 2,995position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 7 papers (2024–2026) · 7 papers (2024–2026) · 7 papers (2024–2026) · 7 papers (2024–2026) · 7 papers (2024–2026) · 7 papers (2024–2026)Lars Køber · Nordsjællands Hospital7 papers (2024–2026)Carsten Schade Larsen · Aarhus University Hospital7 papers (2024–2026)Daniel Modin · Frederiksberg Hospital7 papers (2024–2026)Tor Biering‐Sørensen · University of Copenhagen6 papers (2024–2025)Brian Claggett · Harvard University6 papers (2024–2025)Safia Chatur · Twitter (United States)6 papers (2024–2026)Jens‐Ulrik Stæhr Jensen · University of Copenhagen6 papers (2024–2025)Muthiah Vaduganathan · Harvard University6 papers (2024–2026) · 4 papers (2024–2026)Scott D. Solomon · Harvard University4 papers (2024–2025)Ankeet S. Bhatt · Palo Alto University4 papers (2024–2026) · 3 papers (2024–2025)Scott Solomon · Harvard University2 papers (2024–2024)Steen Ethelberg · Statens Serum Institut2 papers (2022–2022)